Consortium on Beta-cell Death and Survival (HIRN-CBDS) (UC4)

Funding Opportunity RFA-DK-14-021 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) requests applications for the development of medium- to high-throughput "omics" technologies that can be used to explore human pancreatic tissues with single cell- or near single cell- resolution. Successful applicants will join the Consortium on Beta cell Death and Survival (CBDS), whose mission is to identify the mechanisms of beta cell stress and destruction central to the development of Type 1 Diabetes (T1D) in humans, with the long-term goal of protecting the residual beta cell mass in T1D patients as early as possible in the disease process, and preventing the progression towards autoimmunity. CBDS is part of the Human Islet Research Network (HIRN).
Source: NIH Funding Opportunities (Notices, PA, RFA) - Category: Research Source Type: funding